Background: Studies have reported current hormonal contraceptive use is associated with adverse cardiovascular outcomes, including high blood pressure. The aim of this study was to determine the association between past hormonal contraception use and high blood pressure in Australian postmenopausal women. Methods: Women were recruited from the 45 and Up Study, an observational cross-sectional study, conducted from February 2006 to December 2009, NSW Australia. All of the variables used in this study were derived from self-reported data. These women reported being postmenopausal, having an intact uterus, and had given birth to one or more children. Odds ratios and 99% confidence intervals for the association between past hormonal contracepti...
Background: The association between hormonal injection contraceptive and hypertension has been long ...
The progestogen-only pill (POP) is a contraceptive option for women who have high blood pressure eit...
Hypertension is an important modifiable risk factor for cardiovascular (CV) morbidity and mortality,...
The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controvers...
BACKGROUND: The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remain...
Background: The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remain...
Background Oral contraceptives induce hypertension in approximately 5% of users of high-dose pills t...
BACKGROUND: Hypertension (HTN) in pregnancy is a leading cause of maternal mortality in the United S...
Background: The incidence of hypertension in postmenopausal women exceeds that in age-matched men. L...
Abstract Oral contraceptives (OC) are associated with increased risk of hypertension and elevated bl...
OBJECTIVE: The objective of this study was to assess the effect of menopausal hormone therapy (HT) o...
Objective: We analysed risk factors for high blood pressure (BP) among women around menopause. Metho...
Oral contraceptive use is associated with hypertension, dyslipidemias, and insulin resistance, all o...
BACKGROUND AND PURPOSE: Controversy persists as to whether oral contraceptive (OC) use and reproduct...
BACKGROUND AND PURPOSE: Controversy persists as to whether oral contraceptive (OC) use and reproduct...
Background: The association between hormonal injection contraceptive and hypertension has been long ...
The progestogen-only pill (POP) is a contraceptive option for women who have high blood pressure eit...
Hypertension is an important modifiable risk factor for cardiovascular (CV) morbidity and mortality,...
The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remains controvers...
BACKGROUND: The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remain...
Background: The relationship between menopausal hormone therapy (MHT) and cardiovascular risk remain...
Background Oral contraceptives induce hypertension in approximately 5% of users of high-dose pills t...
BACKGROUND: Hypertension (HTN) in pregnancy is a leading cause of maternal mortality in the United S...
Background: The incidence of hypertension in postmenopausal women exceeds that in age-matched men. L...
Abstract Oral contraceptives (OC) are associated with increased risk of hypertension and elevated bl...
OBJECTIVE: The objective of this study was to assess the effect of menopausal hormone therapy (HT) o...
Objective: We analysed risk factors for high blood pressure (BP) among women around menopause. Metho...
Oral contraceptive use is associated with hypertension, dyslipidemias, and insulin resistance, all o...
BACKGROUND AND PURPOSE: Controversy persists as to whether oral contraceptive (OC) use and reproduct...
BACKGROUND AND PURPOSE: Controversy persists as to whether oral contraceptive (OC) use and reproduct...
Background: The association between hormonal injection contraceptive and hypertension has been long ...
The progestogen-only pill (POP) is a contraceptive option for women who have high blood pressure eit...
Hypertension is an important modifiable risk factor for cardiovascular (CV) morbidity and mortality,...